C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
167/202, 195/1.1
C12N 15/61 (2006.01) A61K 48/00 (2006.01) C07K 14/705 (2006.01) C07K 19/00 (2006.01) C12N 9/78 (2006.01) C12N 15/62 (2006.01) C12N 15/85 (2006.01)
Patent
CA 1339654
The present invention is related generally to the construction of fusion genes. More particularly, the present invention is related to the construction of a fusion gene comprising a coding sequence for a selectable marker linked by fusion to another coding sequence, the product of which is desired to be expressed in recipient cells. Gene therapy utilizing an MDR1 linked fusion coding sequence has been disclosed. Adenosine deaminase activity has been introduced into cells using MDR1 linked fusion gene.
601635
Germann Ursula A.
Gottesman Michael
Pastan Ira
Gowling & Henderson
U.s. Departm Ent Of Commerce The United States Of America Represented By The Secretary
LandOfFree
Gene therapy using gene fusion for genetic or acquired... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gene therapy using gene fusion for genetic or acquired..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gene therapy using gene fusion for genetic or acquired... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1289257